Non-coding RNAs and epigenetic mechanisms in vascular remodeling
Vorsitz: D. G. Sedding (Hannover), T. Thum (Hannover)
13:30 | (V19) | Therapeutic potential of modulating non-coding RNAs in atherosclerotic plaques |
L. Maegdefessel (Stockholm, SE) | ||
13:45 | Discussion | |
13:50 | (V20) | Vascular importance of the miR212/132 cluster |
R. Kumarswamy (Hannover) | ||
14:05 | Discussion | |
14:10 | (V21) | Selective inhibition of BET bromodomains as therapeutic option to prevent negative vascular remodeling |
S. Weisheit (Hannover) | ||
14:25 | Discussion | |
14:30 | (V22) | Non-coding RNAs in endothelial cell function |
R. A. Boon (Frankfurt am Main) | ||
14:45 | Discussion | |
14:50 | (V23) | Final discussion |
T. Thum (Hannover) | ||
Im Anschluss: Mitgliederversammlung und Wahlen der AG4 |